Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04296110 · ClinicalTrials.gov registry record · NA

Impact of a Biofeedback Intervention on Microbiome, Metabolome, and Clinical Outcomes in Pediatric IBD (Study 2)

A NA study, sponsored by Nationwide Children's Hospital.

Terminated
Registry status
NA
Development phase
48
Enrollment target

NCT04296110: Clinical Trial NA study, sponsored by Nationwide Children's Hospital.

NCT04296110 is a NA study that was terminated before completion, run by Nationwide Children's Hospital. The registered enrollment target is 48 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04296110, a NA study, was terminated before completion, sponsored by Nationwide Children's Hospital.

TERMINATED
Registry status
NA
Development phase
48 participants
Enrollment target

Study Summary

This prospective, randomized, longitudinal, controlled study will enroll pediatric CD patients with inflammatory, non-stricturing, and non-penetrating disease type with mild/quiescent disease based on Pediatric Crohn's Disease Activity Index (PCDAI). Participants will be randomized to receive HRV biofeedback intervention daily for 12 weeks or to music relaxation therapy.

Primary Outcome

Fecal calprotectin levels from stool

Interventions

  • BEHAVIORAL Biofeedback
  • OTHER Music Relaxation Therapy

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2020-03-12
Est. Completion 2024-08-14
Phase NA
Nationwide Children's Hospital

188 total trials

Why NCT04296110 stopped before completion

NCT04296110 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 2 interventions - of which Biofeedback is the first listed.

NCT04296110 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04296110 about?

NCT04296110 is a clinical study titled "Impact of a Biofeedback Intervention on Microbiome, Metabolome, and Clinical Outcomes in Pediatric IBD (Study 2)". This prospective, randomized, longitudinal, controlled study will enroll pediatric CD patients with inflammatory, non-stricturing, and non-penetrating disease type with mild/quiescent disease based on Pediatric Crohn's Disease Activity Index (PCDAI). Participants will be randomized to receive HRV bi...

What is the current status of trial NCT04296110?

This trial is currently terminated. It is a NA study. The enrollment target is 48 participants. The study started on 2020-03-12. Estimated completion is 2024-08-14.

What interventions are being tested in trial NCT04296110?

The interventions under investigation include: Biofeedback (BEHAVIORAL), Music Relaxation Therapy (OTHER).

Who is sponsoring clinical trial NCT04296110?

This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04296110's enrollment target sits among peer trials

48 1381st of 2000 higher than 601 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01765777 · 48 participants · NA

    Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain

  • NCT03073343 · 48 participants · NA

    A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine

  • NCT03431064 · 48 participants

    Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients

  • NCT03514602 · 48 participants · NA

    Maternal Smoking Cessation and Pediatric Obesity Prevention

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04296110, the US trial registry maintained by the National Library of Medicine. NCT04296110 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.